Health Protection Agency. HIV in the United Kingdom. London: Health Protection Agency, 2011. See http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131685847 (last accessed 8 February 2012)
2.
GrantRM, LamaJR, AndersonPL, Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med2010;363:2587–99
3.
http://depts.washington.edu/uwicrc/research/studies/files/PrEP_PressRelease-UW_13Jul2011.pdf (last accessed 16 January 2012)
4.
http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html (last accessed 16 January 2012)
5.
Abdool KarimQ, Abdool KarimSS, Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science2010;329:1168–74
6.
http://www.fhi360.org/en/Research/Projects/FEM-PrEP.htm (last accessed 8 February 2012)
7.
VOICE: http://www.mtnstopshiv.org/node/3619 (last accessed 16 January 2012)
8.
http://www.cdc.gov/nchhstp/newsroom/PrEPMSMGuidanceGraphic.html (last accessed 16 January 2012)
9.
http://www.bashh.org/guidelines; http://www.bhiva.org/ClinicalGuidelines.aspx (last accessed 16 January 2012)
10.
WellerS, DavidK. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev2002;1:CD003255
11.
CohenMS, ChenYQ, McCauleyM, Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med2011;365:493–505
12.
AttiaS, EggerM, MüllerM, Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS2009;23:1397–404
13.
WeissHA, HalperinD, BaileyRC, Male circumcision for HIV prevention: from evidence to action?AIDS2008;22:567–74
14.
CardoDM, CulverDH, CiesielskiCA, A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med1997;337:1485–90
15.
CelumC, WaldA, LingappaJR, Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Eng J Med2010;362:427–39
16.
HallettTB, AlsallaqRA, BaetenJM, Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect2011;87:88–93
17.
DrezettJ. Post-exposure prophylaxis in raped women. IV International Conference on HIV Infection in Women and Children, Livro De Resumos, Universidade, Federal do Rio De Janeiro e Institute of Virology of Maryland, Rio de Janeiro, Brazil, 2002
18.
HendrixC, MinnisA, GudderaV, A Phase II cross-over study of daily oral and vaginal tenofovir in healthy sexually active women results in significantly different product acceptability and vaginal tissue drug concentrations. Abs 35LB. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011
19.
SánchezJ, SalY, RosasVG, HughesJP, Male circumcision and risk of HIV acquisition among MSM. AIDS2011;25:519–23
20.
SchecterM, do LagoRF, MendelsohnAB, Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr2004;35:519–25
21.
AntonP, CranstonR, Carbello-DieguezA, RMP-02/MTN006 A phase I placebo controlled trial of rectally applied 1% vaginal tenofovir gel, with comparison to oral tenofovir. Abs 34LB. 18th Conference on Retroviruses and Opportunistic Infections, Boston, 2011
